Novo Holdings

Novo Holdings is the holding and investment company for the Novo Nordisk Foundation, managing its substantial assets. It serves as controlling shareholder for Novo Nordisk and Novonesis. The firm maintains a diverse investment portfolio, primarily focusing on life science companies across all developmental stages, alongside strategic holdings in equities, bonds, real estate, and private equity.

Established in 1999 by the Novo Nordisk Foundation, Novo Holdings was created for long-term financial stewardship. The core insight was generating attractive, sustainable investment returns. This approach ensures consistent funding for the Foundation’s philanthropic mission to improve human health and foster environmental sustainability.

The ultimate beneficiaries of Novo Holdings' efforts are global communities and the environment, through initiatives supported by the Novo Nordisk Foundation. Its vision is to be a leading responsible investor, achieving strong financial returns and significant positive societal impact by prioritizing groundbreaking healthcare and bio-sustainability solutions.